The CM-Path biomarker workshop series aims at discussing the current and future challenges of innovative biomarker developments, and agreeing on the barriers for delivery of clinical diagnostics assays.
The first workshop is organized by the CM-Path Discovery Workstream for the following objectives:
- Developing an understanding of various research strategies, study design and their practicality for setting up biomarker discovery and development studies
- With a special focus on emerging technologies for biomarker research using formalin-fixed paraffin-embedded (FFPE) materials
This event is certified for 6 CPD points from the Royal College of Pathologists.
More information is available on the National Cancer Research Institute website.